Pain Therapeutics to Present at the Credit Suisse Healthcare Conference

SAN MATEO, Calif., Nov. 4, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the Credit Suisse Healthcare Conference on Wednesday, November 11th at 2:30 p.m. Mountain Standard Time.

A live audio webcast of the presentation will be available on the company's website homepage at www.paintrials.com. A replay of the audio webcast will continue to be available on the website for thirty days.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. Our lead drug candidate, Remoxy(R), is a strong painkiller with a unique formulation designed to reduce potential risks of unintended use. We are also developing novel drugs in the area of hematology/oncology. In clinical development we have a monoclonal antibody to treat metastatic melanoma, a deadly form of skin cancer. We have in pre-clinical development a drug to treat hemophilia, a genetic disorder in which patients are unable to stop bleeding. The FDA has not approved any of our drug candidates for commercial sale. For more information, please visit www.paintrials.com.

CONTACT:  Pain Therapeutics, Inc.
          Judy Ishida, Administrative Manager
          650-645-1924 
          IR@paintrials.com